Skip to search formSkip to main contentSkip to account menu

Kallmann Syndrome 2 (disorder)

Known as: Kallmann Syndrome 2, KAL2, HH2 
Type 2 is an autosomal dominant form with loss-of-function mutations of gene Kal2 which encodes fibroblast growth-factor receptor-1 (FGFR1 PROTEIN).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Single-component adjuvant is prone to eliciting a specific type of Th1 or Th2 response. So, the development of combinatorial… 
2013
2013
This paper presents a DWT-DCT-SVD based hybrid watermarking method for color images. Robustness is achieved by applying DCT to… 
2006
2006
We developed a simple in vitro antithrombogenic testing method using a mock circulation system as used in the hemolysis tests to… 
Highly Cited
2001
Highly Cited
2001
Herbig–Haro (HH) objects have been known for 50 years to be luminous condensations of gas in star-forming regions, but their… 
1993
1993
Background. The amount of sialic acid correlates with the invasiveness and metastasizing potential of several human tumors. The… 
Highly Cited
1985
Highly Cited
1985
Three hybridomas secreting monoclonal antibodies, HH1, HH2, and HH3, defining different difucosyl A structures (ALeb or ALey… 
1961
1961
BS>The counting of C/sup 14/-labelled substances, soluble and insoluble in the scintillator, at counting efficiencies of 90 and…